High materiality7/10
Arcus Biosciences price target raised to $43 from $41 at Wedbush
Why it may matterVerify against the original reporting
buy
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
Wedbush raises RCUS target to 43; current price 28.79; upside ~49%.
- Wedbush target: RCUS 43 vs price 28.79
Key facts
- 01
Target: $43
- 02
Posted price: $28.79
- 03
Analyst firm: Wedbush
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.